- Home
- FOR vs CRMD Comparison
FOR vs CRMD Comparison
Compare FOR & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOR
- CRMD
- Stock Information
- Founded
- FOR 2005
- CRMD 2006
- Country
- FOR United States
- CRMD United States
- Employees
- FOR N/A
- CRMD N/A
- Industry
- FOR Real Estate
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- FOR Finance
- CRMD Health Care
- Exchange
- FOR Nasdaq
- CRMD Nasdaq
- Market Cap
- FOR 1.0B
- CRMD 973.3M
- IPO Year
- FOR 2007
- CRMD 2010
- Fundamental
- Price
- FOR $21.73
- CRMD $11.40
- Analyst Decision
- FOR Strong Buy
- CRMD Strong Buy
- Analyst Count
- FOR 3
- CRMD 7
- Target Price
- FOR $30.33
- CRMD $17.33
- AVG Volume (30 Days)
- FOR 150.8K
- CRMD 2.5M
- Earning Date
- FOR 07-22-2025
- CRMD 08-13-2025
- Dividend Yield
- FOR N/A
- CRMD N/A
- EPS Growth
- FOR N/A
- CRMD N/A
- EPS
- FOR 3.29
- CRMD 0.28
- Revenue
- FOR $1,471,000,000.00
- CRMD $82,553,827.00
- Revenue This Year
- FOR $3.95
- CRMD $238.38
- Revenue Next Year
- FOR $8.86
- CRMD $53.52
- P/E Ratio
- FOR $6.61
- CRMD $41.86
- Revenue Growth
- FOR N/A
- CRMD N/A
- 52 Week Low
- FOR $18.00
- CRMD $3.61
- 52 Week High
- FOR $37.21
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- FOR 66.84
- CRMD 39.52
- Support Level
- FOR $19.88
- CRMD $12.14
- Resistance Level
- FOR $21.92
- CRMD $17.43
- Average True Range (ATR)
- FOR 0.67
- CRMD 0.69
- MACD
- FOR 0.21
- CRMD -0.51
- Stochastic Oscillator
- FOR 92.86
- CRMD 4.60
About FOR Forestar Group Inc
Forestar Group Inc is a residential lot development company with operations across the United States. The core business segment for the company is real estate which generates all of it's revenues. The firm fundamentally acquires entitled real estate and develops it into finished residential lots for sale to homebuilders with a strategic focus on asset turns and efficiency. Single-family residential communities account for the majority of their real estate projects. The company utilizes a lower-risk business model mainly by investing in short duration, phased development projects.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.